Aer Therapeutics
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $16M
Investors
- 3
About Aer Therapeutics
Based in Raleigh, US, and founded in 2014, Aer Therapeutics, a spin-out of Dr. John Fahy’s airway biology lab at the University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry lab at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics lab at Trinity College Dublin, operates as a clinical-stage biopharmaceutical company that develops novel therapeutics to treat respiratory diseases. The company develops novel inhaled treatments for muco-obstructive lung diseases like asthma, cystic fibrosis, primary ciliary dyskinesia, and non-cystic fibrosis bronchiectasis. AER-01, a thiol-modified carbohydrate, is a product of the company that cleaves mucin disulfide bridges to liquefy mucus plugs, disulfide bridges cross-link mucin polymers, increasing mucus gel elasticity and promote mucus plug formation.
Who invested in Aer Therapeutics
3 investors across 1 round
See all investors in Aer Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 9, 2022
Amount
$16M
Investors
Questions about Aer Therapeutics
Who invested in Aer Therapeutics?
Aer Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aer Therapeutics raised?
Aer Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aer Therapeutics last raise money?
Aer Therapeutics's most recent round on record is a Series A, in Dec 2022.
What does Aer Therapeutics do?
Based in Raleigh, US, and founded in 2014, Aer Therapeutics, a spin-out of Dr.
Where is Aer Therapeutics headquartered?
Aer Therapeutics is headquartered in Raleigh, US.
Which VCs invest in companies like Aer Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aer Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aer Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.